Actively Recruiting
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Led by Alzheimer's Light LLC · Updated on 2024-08-01
2000
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease. This project will test the ability of a novel iPad App (AlzLife https://www.alz.life/) that delivers light therapy at 40 Hz combined with cognitive therapy to improve cognition, function, and quality of life in Alzheimer's disease.
CONDITIONS
Official Title
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Alzheimer's disease
- Cognitive Impairment
You will not qualify if you...
- Any previously noted epileptic seizures, including febrile seizures
- Any significant disease of the eye, such as macular degeneration, requiring healthy eyes for light therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Andrey Vyshedskiy
Miami, Florida, United States, 33156
Actively Recruiting
Research Team
A
Andrey Vyshedskiy, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here